Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study
Daniela Tomasoni, Riccardo M. Inciardi, Carlo Lombardi, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 12, pp. 2238-2247
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Circulation (2022) Vol. 145, Iss. 18
Open Access | Times Cited: 2913
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 17, pp. e263-e421
Open Access | Times Cited: 1465
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
Colin Baigent, Stephan Windecker, Daniele Andreini, et al.
European Heart Journal (2021) Vol. 43, Iss. 11, pp. 1059-1103
Open Access | Times Cited: 147
Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
Eleni Karakike, Evangelos J. Giamarellos‐Bourboulis, Miltiades Kyprianou, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 12, pp. 2042-2057
Open Access | Times Cited: 140
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae
Leonardo Italia, Daniela Tomasoni, Stefano Bisegna, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 115
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
Colin Baigent, Stephan Windecker, Daniele Andreini, et al.
European Heart Journal (2021) Vol. 43, Iss. 11, pp. 1033-1058
Open Access | Times Cited: 107
Impact of COVID-19 on Cardiovascular Disease
Ivan Vosko, Andreas Zirlik, Heiko Bugger
Viruses (2023) Vol. 15, Iss. 2, pp. 508-508
Open Access | Times Cited: 63
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
Thomas M. Maddox, James L. Januzzi, Larry A. Allen, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 15, pp. 1444-1488
Closed Access | Times Cited: 63
2024 update in heart failure
Alberto Beghini, Antonio Maria Sammartino, Z. Papp, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 28
COVID and Cardiovascular Disease: What We Know in 2021
Michael Chilazi, Eamon Duffy, Aarti Thakkar, et al.
Current Atherosclerosis Reports (2021) Vol. 23, Iss. 7
Open Access | Times Cited: 98
Heart failure: an update from the last years and a look at the near future
Mauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3667-3693
Open Access | Times Cited: 49
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
Colin Baigent, Stephan Windecker, Daniele Andreini, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 7, pp. 1618-1666
Open Access | Times Cited: 52
A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity
Jie Xu, Wenwei Xiao, Xuan Liang, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 49
Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
Marijke Linschoten, Alicia Uijl, Astrid Schut, et al.
European Heart Journal (2021) Vol. 43, Iss. 11, pp. 1104-1120
Open Access | Times Cited: 49
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study
Sara París, Riccardo M. Inciardi, Carlo Lombardi, et al.
EP Europace (2021) Vol. 23, Iss. 10, pp. 1603-1611
Open Access | Times Cited: 46
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
Colin Baigent, Stephan Windecker, Daniele Andreini, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 6, pp. 1385-1412
Open Access | Times Cited: 45
International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19
G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, et al.
Russian Journal of Cardiology (2021) Vol. 26, Iss. 4, pp. 4470-4470
Open Access | Times Cited: 44
New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19
Jesús Álvarez‐García, Suraj K. Jaladanki, Mercedes Rivas‐Lasarte, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 17, pp. 2260-2262
Open Access | Times Cited: 43
Meta-Analysis of Atrial Fibrillation in Patients With COVID-19
Haiyan Yang, Xuan Liang, Jie Xu, et al.
The American Journal of Cardiology (2021) Vol. 144, pp. 152-156
Open Access | Times Cited: 41
Impact of COVID‐19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV‐HF‐SIRIO 6 study)
Jacek Kubica, Małgorzata Ostrowska, Wioleta Stolarek, et al.
ESC Heart Failure (2021) Vol. 9, Iss. 1, pp. 721-728
Open Access | Times Cited: 40
Heart failure during the COVID‐19 pandemic: clinical, diagnostic, management, and organizational dilemmas
Alberto Palazzuoli, Marco Metra, Sean P. Collins, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3713-3736
Open Access | Times Cited: 28
A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality
Angelo Zinellu, Arduino A. Mangoni
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 11, pp. 1187-1202
Closed Access | Times Cited: 27
Cell-Specific Mechanisms in the Heart of COVID-19 Patients
Emily J. Tsai, Daniela Čiháková, Nathan R. Tucker
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1290-1301
Open Access | Times Cited: 17
Trends and outcomes of heart failure hospitalizations during COVID-19 pandemic
Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
A year in heart failure: an update of recent findings
Lorenzo Stretti, Dauphine Zippo, Andrew J.S. Coats, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 6, pp. 4370-4393
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top